Predicting hepatitis B flare in treatment-naive patients with chronic hepatitis B

被引：0
|
作者：
Con, D. [1 ]
Tu, S. [1 ]
Clayton-Chubb, D. [2 ]
Lubel, J. [2 ]
Nicoll, A. [1 ]
Bloom, S. [1 ]
Sawhney, R. [1 ]
机构：
[1] Eastern Hlth, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Alfred Hlth, Dept Gastroenterol, Melbourne, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
112
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [1] Hepatitis B virus quasispecies in the polymerase gene in treatment-naive chronic hepatitis B patients
    Kim, D. Y.
    Ahn, S. H.
    Chang, H. Y.
    Shim, H. Y.
    Heo, J.
    Cho, M.
    Moon, B. S.
    Moon, Y. M.
    Paik, Y. H.
    Lee, K. S.
    Han, K. H.
    Chon, C. Y.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S211 - S211
  • [2] Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B
    Nguyen, M. H.
    Garcia, R. T.
    Trinh, H. N.
    Nguyen, H. A.
    Nguyen, K. K.
    Nguyen, L. H.
    Levitt, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (11-12) : 1150 - 1158
  • [3] Role of quantitative hepatitis B surface antigen levels in predicting liver biopsy time in treatment-naive chronic hepatitis B patients
    Tatar, Bengu
    Acar, Ayse
    Adar, Pelin
    Kose, Sukran
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 6 (01) : 55 - 59
  • [4] Entecavir therapy for treatment-naive chronic hepatitis B patients in Taiwan
    Dai, C.
    Yeh, M.
    Huang, C.
    Huang, C.
    Hou, N.
    Hsieh, M.
    Huang, J.
    Lin, Z.
    Chen, S.
    Tsai, J.
    Yu, M.
    Chuang, W.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 : 25 - 26
  • [5] Association of liver fibrosis and hypophosphatemia in treatment-naive patients with chronic hepatitis B
    Jiang, Suling
    Wang, Jian
    Zhu, Li
    Zhang, Zhiyi
    Zhan, Jie
    Ding, Weimao
    Li, Jie
    Zhu, Chuanwu
    Huang, Rui
    Wu, Chao
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1078 - S1079
  • [6] Autonomic impairment in treatment-naive patients with chronic hepatitis B and C infections
    Huang, Chih-Cheng
    Wu, Keng-Liang
    Liu, Jia-Shou
    Chang, Yung-Yee
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2022, 238
  • [7] Factors Predicting the Efficacy of Adefovir Dipivoxil on Treatment-Naive Chronic Hepatitis B Patients at 48 Weeks
    Wang, Li-Chun
    Chen, En-Qiang
    Zhu, Xiao-Feng
    Xiong, Zhong-Hua
    Liu, Li
    Xu, Lu
    Lei, Xue-Zhong
    Liu, Cong
    Tang, Hong
    GUT AND LIVER, 2011, 5 (04) : 478 - 485
  • [8] Tenofovir is Superior to Entecavir in Patients with Treatment-naive Hepatitis B e-Antigen-Positive Chronic Hepatitis B
    Behera, Manas K.
    Pati, Girish K.
    Narayan, Jimmy
    Mishra, Debakanta
    Meher, Lalit K.
    Singh, Ayaskant
    Uthansingh, Kanishka
    Sahu, Manoj K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 11 (01) : 37 - 44
  • [9] Response to tenofovir treatment of treatment-naive and adefovir experienced patients with chronic hepatitis b
    Keskin, Onur
    Ormeci, Asli Cifcibasi
    Kabacam, Gokhan
    Akyuz, Filiz
    Aniktar, Hatice
    Karaca, Cetin
    Idilman, Ramazan
    Kaymakoglu, Sabahattin
    Yurdaydin, Cihan
    HEPATOLOGY, 2012, 56 : 394A - 395A
  • [10] Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B
    Chon, Young Eun
    Kim, Seung Up
    Lee, Chun Kyon
    Heo, Jeong
    Kim, Ja Kyung
    Yoon, Ki Tae
    Cho, Mong
    Lee, Kwan Sik
    Kim, Dong Hwan
    Choi, Eun Hee
    Park, Jun Yong
    Kim, Do Young
    Chon, Chae Yoon
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    ANTIVIRAL THERAPY, 2011, 16 (04) : 469 - 477
12345